Medical Condition News

RSS

Heart attack survivors may have a lower risk of Parkinson's disease

People who have had a heart attack may be slightly less likely than people in the general population to develop Parkinson's disease later in life, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

16 Feb 2022

Study shows the true prevalence of statin intolerance worldwide is between 6 to 10%

As many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause muscle pain and other side-effects.

16 Feb 2022

Pioneering treatment for stroke due to intracerebral hemorrhage

For decades, University of Cincinnati researchers have been pioneers in the field of stroke research.

16 Feb 2022

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

A new study discusses the state of current knowledge about the potential use of tea polyphenols in the prevention and treatment of COVID-19.

16 Feb 2022

Children with severe COVID-19 show low mucosal neutralizing activity against SARS-CoV-2

A new study examines neutralizing responses to the ancestral variant of SARS-CoV-2, as well as against later variants of concern.

16 Feb 2022

COVID-19 related placental tissue destruction and insufficiency may cause stillbirth and neonatal death from hypoxic-ischemic injury

Researchers evaluate the role of the placenta in causing stillbirth and neonatal death post-maternal COVID-19 and confirmed placental positivity for SARS-CoV-2.

16 Feb 2022

Study examines lyophilized mRNA-lipid nanoparticle vaccines with long-term stability

A new study explored the high immunogenicity and stability of lyophilized mRNA-LNP vaccines in relation to SARS-CoV-2.

16 Feb 2022

Study explores how the electrostatic charge of the SARS-CoV-2 spike protein has changed over time

In a new study, researchers examined the effect of electrostatic changes on the ability of the SARS-CoV-2 Omicron variant to escape immunity.

16 Feb 2022

Omicron RBD-ACE2 binding found to be stronger than wild type SARS-CoV-2 strain

Researchers recently investigated the effect of SARS-CoV-2 Omicron variant mutations on the binding of the receptor-binding domain and angiotensin-converting enzyme-2 to study the overall binding profile of the RBD-ACE2 system.

16 Feb 2022

COVID-19 vaccine boosters shown to confer protection against the SARS-CoV-2 Omicron variant

In a new study, researchers investigated whether a COVID-19 vaccine booster dose is effective against the SARS-CoV-2 Omicron variant.

16 Feb 2022

Researchers to test personalized physical activity programs for stroke survivors

A Melbourne researcher has been awarded a $69,980 Stroke Foundation Seed Grant to investigate what level of physical activity is needed in stroke recovery to have a positive effect on health.

16 Feb 2022

Study to determine the best ways for supporting stroke patients' families

A new study has been designed to determine the best ways to support an entire family unit after a parent has a stroke.

15 Feb 2022

New project aims to improve the lives of stroke survivors with aphasia

A Queensland researcher will lead a new project aimed at improving the lives of people with aphasia, a debilitating condition that impacts one in three survivors of stroke.

15 Feb 2022

New research aims to reduce dysphagia after stroke

New research, aimed at reducing the debilitating impact of the condition dysphagia after stroke, is among the recipients of the Stroke Foundation 2022 Research Grants program.

15 Feb 2022

The long-term consequences of SARS-CoV-2 infection in people with HIV

In a recent study posted to the medRxiv* preprint server, an interdisciplinary team of researchers from the United States (US) analyzed a cohort of patients with human immunodeficiency virus (HIV) (PWH) recovering from coronavirus disease 2019 (COVID-19) and characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune responses in these patients.

15 Feb 2022

Use of immunosuppressants for inflammatory rheumatic diseases and the associated risk of severe COVID-19

A recent study posted to the medRxiv* preprint server investigated the risk of severe/fatal coronavirus disease 2019 (COVID-19) in patients treated with immunosuppressants for inflammatory rheumatic diseases (IRD).

15 Feb 2022

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Long-term survival data from the first prospective, randomized biomarker validation trial in patients with muscle-invasive bladder cancer being treated with cisplatin-based chemotherapy before surgery will be reported at the 2022 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (GU ASCO) on February 18, 2022.

15 Feb 2022

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

Virginia Commonwealth University will radically expand treatment options for liver and liver-related metabolic diseases thanks to a historic, transformational $104 million gift from Richard Todd Stravitz, M.D., and his family's Barbara Brunckhorst Foundation.

15 Feb 2022

Study uncovers most critical genes that cause coronary heart disease

The most critical genes that cause coronary heart disease and trigger heart attacks have been identified in a major new study.

15 Feb 2022

Two doses of psilocybin may ease depression symptoms for up to 12 months

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month.

15 Feb 2022

Medical Condition News

Heart attack survivors may have a lower risk of Parkinson's disease

Study shows the true prevalence of statin intolerance worldwide is between 6 to 10%

Pioneering treatment for stroke due to intracerebral hemorrhage

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

Children with severe COVID-19 show low mucosal neutralizing activity against SARS-CoV-2

COVID-19 related placental tissue destruction and insufficiency may cause stillbirth and neonatal death from hypoxic-ischemic injury

Study examines lyophilized mRNA-lipid nanoparticle vaccines with long-term stability

Study explores how the electrostatic charge of the SARS-CoV-2 spike protein has changed over time

Omicron RBD-ACE2 binding found to be stronger than wild type SARS-CoV-2 strain

COVID-19 vaccine boosters shown to confer protection against the SARS-CoV-2 Omicron variant

Researchers to test personalized physical activity programs for stroke survivors

Study to determine the best ways for supporting stroke patients' families

New project aims to improve the lives of stroke survivors with aphasia

New research aims to reduce dysphagia after stroke

The long-term consequences of SARS-CoV-2 infection in people with HIV

Use of immunosuppressants for inflammatory rheumatic diseases and the associated risk of severe COVID-19

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

Study uncovers most critical genes that cause coronary heart disease

Two doses of psilocybin may ease depression symptoms for up to 12 months

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News